Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,732 | 424 | 99.6% |
| Education | $24.25 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,243 | 72 | $0 (2024) |
| Lilly USA, LLC | $839.32 | 54 | $0 (2024) |
| PFIZER INC. | $774.97 | 73 | $0 (2024) |
| ABBVIE INC. | $684.48 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $599.02 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $589.90 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $315.13 | 20 | $0 (2023) |
| Merck Sharp & Dohme LLC | $291.09 | 17 | $0 (2024) |
| Amarin Pharma Inc. | $171.41 | 9 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $138.27 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $961.05 | 49 | Lilly USA, LLC ($205.55) |
| 2023 | $1,007 | 55 | Novo Nordisk Inc ($195.60) |
| 2022 | $893.30 | 51 | Novo Nordisk Inc ($180.81) |
| 2021 | $1,016 | 62 | Novo Nordisk Inc ($237.58) |
| 2020 | $976.95 | 60 | Novo Nordisk Inc ($206.34) |
| 2019 | $556.05 | 42 | Novo Nordisk Inc ($151.27) |
| 2018 | $679.62 | 48 | Novo Nordisk Inc ($150.33) |
| 2017 | $665.82 | 63 | Lilly USA, LLC ($178.30) |
All Payment Transactions
430 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: VACCINE | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Endocrinology | ||||||
| 08/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Obesity | ||||||
| 08/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Hematology | ||||||
| 08/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 570 | 687 | $185,213 | $51,619 |
| 2022 | 7 | 643 | 802 | $207,274 | $54,632 |
| 2021 | 8 | 683 | 935 | $221,622 | $58,275 |
| 2020 | 10 | 799 | 1,065 | $235,681 | $54,062 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 144 | 144 | $49,536 | $17,734 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 231 | $77,154 | $16,941 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 190 | $42,560 | $10,616 | 24.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 59 | 59 | $10,797 | $4,473 | 41.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $5,166 | $1,855 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 284 | $94,856 | $21,064 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 122 | 122 | $41,968 | $15,363 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 241 | $53,984 | $12,449 | 23.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 38 | 39 | $7,137 | $2,588 | 36.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 69 | $5,658 | $1,927 | 34.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 32 | 32 | $2,816 | $977.15 | 34.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 15 | 15 | $855.00 | $263.61 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 208 | 338 | $112,892 | $27,743 | 24.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 180 | 301 | $67,424 | $17,128 | 25.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 106 | 106 | $19,398 | $6,975 | 36.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $5,504 | $2,069 | 37.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 127 | 128 | $10,496 | $2,066 | 19.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $3,000 | $1,499 | 50.0% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 20 | 20 | $1,760 | $566.02 | 32.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $1,148 | $229.36 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 204 | 307 | $102,418 | $19,680 | 19.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 201 | 355 | $79,536 | $16,337 | 20.5% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 82 | 82 | $14,678 | $4,881 | 33.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 13 | 13 | $4,290 | $2,952 | 68.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 24 | 24 | $6,000 | $2,721 | 45.4% |
About Dr. Daniel Bee, DO
Dr. Daniel Bee, DO is a Family Medicine healthcare provider based in Hermitage, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316914633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Bee, DO has received a total of $6,756 in payments from pharmaceutical and medical device companies, with $961.05 received in 2024. These payments were reported across 430 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,732).
As a Medicare-enrolled provider, Bee has provided services to 2,695 Medicare beneficiaries, totaling 3,489 services with total Medicare billing of $218,588. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hermitage, PA
- Active Since 03/06/2006
- Last Updated 07/15/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316914633
Products in Payments
- Ozempic (Drug) $754.04
- FARXIGA (Drug) $495.55
- TRELEGY ELLIPTA (Drug) $411.12
- JARDIANCE (Drug) $391.50
- TRULICITY (Drug) $375.86
- Rybelsus (Drug) $238.55
- CHANTIX (Drug) $237.89
- ELIQUIS (Drug) $211.36
- Vascepa (Drug) $171.41
- PREVNAR 13 (Biological) $170.20
- CREON (Drug) $142.59
- Creon (Drug) $131.84
- UBRELVY (Drug) $117.68
- BASAGLAR (Drug) $115.24
- Victoza (Drug) $114.60
- MOUNJARO (Drug) $111.21
- JANUVIA (Drug) $87.15
- XARELTO (Drug) $84.91
- VRAYLAR (Drug) $82.66
- PREVNAR - 13 (Biological) $80.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hermitage
Richard Pak, Md, MD
Family Medicine — Payments: $20,563
Dr. Charles D'auria, D.o, D.O
Family Medicine — Payments: $19,203
Dr. Heather Porter, D.o, D.O
Family Medicine — Payments: $17,422
Robert Gaston, Md, MD
Family Medicine — Payments: $16,063
Mindi Hamby, Md, MD
Family Medicine — Payments: $15,709
Richard Stigliano
Family Medicine — Payments: $14,985